Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; water for injections; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalamol 50/5 should not be used to initiate therapy.

Kanada - angličtina - Health Canada

therapeutic foods co. - eye tissue extract - tablet - 180mg - eye tissue extract 180mg - glands and other foods

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - tafluprost, quantity: 0.015 mg/ml - eye drops - excipient ingredients: polysorbate 80; glycerol; sodium hydroxide; monobasic sodium phosphate dihydrate; water for injections; disodium edetate; hydrochloric acid - saflutan is indicated for the reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension, as monotherapy or as adjunctive therapy to beta blockers.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt preservative free is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); brinzolamide, quantity: 10 mg/ml - eye drops - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium chloride; tyloxapol; carbomer 974p; mannitol; sodium hydroxide; disodium edetate; purified water - decrease of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension for whom monotherapy with either component provides insufficient iop reduction.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

care pharmaceuticals pty ltd - ketotifen fumarate, quantity: 0.345 mg/ml (equivalent: ketotifen fumarate, qty 0.25 mg/ml; equivalent: ketotifen, qty 0.25 mg/ml) - eye drops, solution - excipient ingredients: glycerol; water for injections; sodium hydroxide - the symptomatic short term treatment of seasonal allergic conjuctivitis in adults and children 3 years or older.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; dibasic sodium phosphate; water for injections; sodium chloride; hydrochloric acid; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanocom should not be used to initiate therapy.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - travoprost, quantity: 40 microgram/ml; timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: ethoxylated hydrogenated castor oil; sodium hydroxide; propylene glycol; hydrochloric acid; sodium chloride; mannitol; boric acid; purified water; polyquaternium-1 - duotrav is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient intraocular pressure reduction.

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - chloramphenicol - eye drops - 5mg/1ml